EU
EUDA.US EUDA Health Holdings Limited
- Market cap
- USD 46.6M
- P/E
- -
- P/B
- 7.76x
- ROE
- -26.6%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is EUDA.US undervalued?
Graham numberThe Graham number of EUDA Health Holdings Limited cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
EUDA Health Holdings Limited fundamental analysis
No fundamental analysis for EUDA Health Holdings Limited yet.
EUDA Health Holdings Limited stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About EUDA Health Holdings Limited
EUDA Health Holdings Limited engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China. It offers bioenergy cabin therapy packages; stem cell therapy services through third-party treatment centers; and holistic wellness consumer products and services. The company also provides property management services. The company was founded in 2019 and is headquartered in Singapore.
Full company profileEUDA Health Holdings Limited financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
EUDA Health Holdings Limited annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 8.88M | 4.56M | 3.76M | 3.71M | 4.01M | 6.82M | 6.94M |
| Gross Profit | 3.89M | 1.25M | 870K | 842K | 762K | 2.99M | 2.56M |
| Operating Income | -894K | -560K | -5.72M | -3.96M | -17.3M | -2.44M | -1.52M |
| EBITDA | -608K | 1.34M | -24.6M | -8.29M | -17.4M | -2.09M | -1.29M |
| Net Income | 176K | 865K | -24.9M | -10.0M | -15.4M | -2.77M | -1.59M |
| EPS | 0.47 | 1.87 | -41 | -8.77 | -9.46 | -1.49 | -0.65 |
| Balance Sheet | |||||||
| Total Assets | 5.88M | 8.00M | 25.6M | 1.31M | 1.73M | 1.72M | 9.68M |
| Total Liabilities | 6.20M | 7.40M | 29.1M | 8.79M | 4.30M | 5.98M | 3.72M |
| Shareholders' Equity | -361K | 521K | -3.52M | -7.50M | -2.55M | -4.25M | 5.98M |
| Cash & Short-term Investments | 251K | 190K | 57.5K | 189K | 238K | 345K | 366K |
| Total Debt | 710K | 462K | 3.63M | 3.37M | 1.27M | 2.40M | 340K |
| Cash Flow | |||||||
| Operating Cash Flow | -412K | 444K | -1.53M | -2.92M | -2.03M | -2.43M | -2.41M |
| Capital Expenditure | 76.1K | 1.96K | 18.1K | 5.00 | 116K | 104K | 155K |
| Free Cash Flow | -488K | 442K | -1.54M | -2.92M | -2.15M | -2.53M | -2.41M |
| Ratios | |||||||
| ROE | - | 165.9% | - | - | - | - | -26.6% |
| ROA | 3.0% | 10.8% | -97.1% | -766.1% | -887.7% | -161.5% | -16.4% |
| Net Profit Margin | 2.0% | 19.0% | -661.1% | -270.9% | -382.9% | -40.7% | -22.9% |
| Debt to Equity | - | 0.89x | - | - | - | - | 0.06x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
EUDA Health Holdings Limited dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | USD 1.31M | 2.17 | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:20 on Mar 23, 2026.
Who owns EUDA Health Holdings Limited
- Insiders 48.22%
- Institutions 0.00%
- Public & others 51.78%
- Shares outstanding 2.99M
- Free float 1.76M
Top funds holding EUDA.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Fidelity Nasdaq Composite Index | 895.00 | 0.03% | 0.00% | Aug 2026 |
Top institutions holding EUDA.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| UBS Group AG | 22.00 | 0.00% | 0.00% | Jun 2026 |
EUDA Health Holdings Limited company profile
- Company name
- EUDA Health Holdings Limited
- Ticker
- EUDA.US
- ISIN
- VGG3142E1473
- Exchange
- USA Stocks
- Listed since
- Dec 14, 2021
- Sector
- Real Estate
- Industry
- Health Care Providers & Services
- Employees
- 123
- Fiscal year end
- December
- Address
- 60 Kaki Bukit Place, Singapore, Singapore, 415979
- Phone
- 65 6327 1110
- Website
- eudahealth.com
About EUDA Health Holdings Limited
EUDA Health Holdings Limited engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China. It offers bioenergy cabin therapy packages; stem cell therapy services through third-party treatment centers; and holistic wellness consumer products and services. The company also provides property management services. The company was founded in 2019 and is headquartered in Singapore.
EUDA Health Holdings Limited management
5- Mr. Daniel TanChief Technology Officer · born 1982
- Mr. Alfred LimCEO & Executive Director · born 1952
- Ms. Whye Shin TayInterim Chief Financial Officer · born 1986
- Mr. Aaron LimOperational Director
- Mr. Johnson TangManaging Director of EUDA Health Malaysia Sdn Bhd